D
Charles River Laboratories International, Inc. CRL
$178.14 -$0.80-0.45% NYSE
Recommendation
Prev Close
$178.14
Volume
225,766
Avg Vol (90D)
996,412
Market Cap
$8.77B
Dividend & Yield
--
52-Week Range
$91.86 - $203.01
P/E (TTM)
--
EPS (TTM)
-$1.56
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
The 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid?
4/16/2025 - MarketBeat
Swiss National Bank Lowers Stock Holdings in Charles River Laboratories International, Inc. $CRL
11/29/2025 - MarketBeat
Jefferies Financial Group Inc. Cuts Holdings in Charles River Laboratories International, Inc. $CRL
11/28/2025 - MarketBeat
Charles River Laboratories International, Inc. $CRL Shares Sold by Franklin Resources Inc.
11/28/2025 - MarketBeat
Charles River Laboratories International (CRL, $178.05) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 25, 2025
11/26/2025 - Tickeron - Stocks
Charles River Laboratories International (CRL, $178.05) price may drop as it broke higher Bollinger Band on Nov 25, 2025
11/26/2025 - Tickeron - Stocks
Charles River Laboratories International, Inc. $CRL Shares Sold by Horizon Kinetics Asset Management LLC
11/25/2025 - MarketBeat
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
11/24/2025 - Business Wire
How Does Charles River (CRL) Balance Cautious Guidance with Outperforming Q3 Results?
11/24/2025 - Simply Wall St
LSV Asset Management Purchases New Position in Charles River Laboratories International, Inc. $CRL
11/22/2025 - MarketBeat
Tpg Larger Than S&P 500 Component Charles River Laboratories International
11/21/2025 - The Online Investor
Charles River Laboratories International, Inc. $CRL Shares Sold by Primecap Management Co. CA
11/21/2025 - MarketBeat
KBC Group NV Sells 74,940 Shares of Charles River Laboratories International, Inc. $CRL
11/20/2025 - MarketBeat
Charles River Laboratories International (NYSE:CRL) Upgraded at Argus
11/20/2025 - Ticker Report
Charles River Laboratories (CRL): Assessing Valuation After Latest Share Price Pullback
11/18/2025 - Simply Wall St
Charles River Laboratories International, Inc. (CRL) Presents at Jefferies London Healthcare Conference 2025 Transcript
11/18/2025 - SeekingAlpha
Charles River Laboratories International, Inc. (CRL) Presents at Jefferies London Healthcare Conference 2025 Transcript
11/18/2025 - Seeking Alpha: Transcripts
Charles River Laboratories International (NYSE:CRL) Upgraded to "Buy" at Argus
11/18/2025 - MarketBeat
Empower Advisory Group LLC Has $333,000 Stock Holdings in Charles River Laboratories International, Inc. $CRL
11/18/2025 - MarketBeat
Geode Capital Management LLC Has $186.60 Million Stock Position in Charles River Laboratories International, Inc. $CRL
11/18/2025 - MarketBeat
Charles River (CRL) International Revenue Performance Explored
11/17/2025 - Zacks Investment Research
Charles River Laboratories to Present at Jefferies Global Healthcare Conference
11/17/2025 - GuruFocus
Charles River Laboratories to Present at Jefferies Global Healthcare Conference
11/17/2025 - Business Wire
Banco Bilbao Vizcaya Argentaria S.A. Has $2.15 Million Stake in Charles River Laboratories International, Inc. $CRL
11/17/2025 - MarketBeat
Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest
11/17/2025 - StockStory Articles
Income Statement
Total Revenue (TTM)
$4.02B
EBITDA (TTM)
$889.39M
EBIT (TTM)
$542.65M
Net Income (TTM)
-$82.28M
Balance Sheet
Total Assets (Q)
$7.51B
Total Debt (Q)
$2.63B
Total Liabilities (Q)
$4.06B
Book Value Per Share (Q)
$69.20
Cash Flow
Cash from Operations (TTM)
$749.49M
Cash from Investing (TTM)
-$192.62M
Cash from Financing (TTM)
-$560.74M
Net Change in Cash (TTM)
-$2.42M
Filings
Filing Date
Wednesday, November 5, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 16 and 20 (est)
Price History
Loading...
Beta
1.35
7-Day Total Return
10.21%
30-Day Total Return
-0.21%
60-Day Total Return
8.63%
90-Day Total Return
0.59%
Year to Date Total Return
-2.46%
1-Year Total Return
-10.51%
2-Year Total Return
-9.62%
3-Year Total Return
-25.62%
5-Year Total Return
-24.04%
52-week Low
Apr 11, 2025 - $91.86
52-week High
Dec 02, 2024 - $203.01
Valuation
Market Cap
$8.77B - Mid Cap
Enterprise Value
$11.24B
Price/Sales (TTM)
2.19
Price/Book (Q)
2.57
Dividends and Shares
Shares Outstanding
49.43
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.criver.com
Phone Number
781 222 6000
Address
251 Ballardvale Street
Wilmington, MA 01887
Country
United States
Year Founded
1947
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and... more
NYSE 11/28/2025 1:00PM Eastern Quotes delayed